PHARMACEUTICAL, BIOMEDICAL AND MEDICAL TECHNOLOGY COMPETENCE CENTRE (Q3056554)
Jump to navigation
Jump to search
Project Q3056554 in Latvia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PHARMACEUTICAL, BIOMEDICAL AND MEDICAL TECHNOLOGY COMPETENCE CENTRE |
Project Q3056554 in Latvia |
Statements
3,156,226.22 Euro
0 references
6,800,150.21 Euro
0 references
46.41 percent
0 references
21 September 2016
0 references
31 December 2018
0 references
SIA "Farmācijas, biomedicīnas un medicīnas tehnoloģiju Kompetences centrs"
0 references
56°54'41.11"N, 24°8'39.98"E
0 references
Farmācijas, biomedicīnas un medicīnas tehnoloģiju Kompetences centrs aptver divus zinātniskos virzienus:•Farmācija, oriģinālzāles un ģenēriskās zāles – aktīvo medicīnas vielu izpēte jaunu t.sk. patentbrīvo medikamentu izstrādei, specifisku vielu novērtēšana konkrētu slimību ārstēšanai u.tml.;•Dabas vielu zāles, uztura bagātinātāji, funkcionālā kosmētika – izstrādāt jaunus kosmētikas produktus, atbilstoši kosmētikas nozares tendencēm.Kompetences centra mērķis ir atbalstīt vismaz 13 pētījumus atbilstoši definētajiem pētniecības virzieniem, attīstot jaunus produktus un tehnoloģijas nozarē un ieviešot tās ražošanā, tādējādi veicinot pētniecības un rūpniecības sektora sadarbību, kā arī nozares komersantu konkurētspējas paaugstināšanu.Projekts tiks īstenots Latvijas viedās specializācijas stratēģijas jomā – “Biomedicīna, medicīnas tehnoloģijas, biofarmācija un biotehnoloģijas”.Kompetences centra darbības rezultātā plānots atbalstīt vismaz 13 pētniecības projektus, vismaz 9 komersantus, kas turpmāk ieviesīs ražošanā jaunus produktus vai tehnoloģijas.Projekta kopējās pētījumu izmaksas sastāda virs 7 miljoniem eiro, plānotais Eiropas Reģionālās attīstības fonda (turpmāk – ERAF) atbalsta apjoms – 3 206 250 EUR.Projektu plānots īstenot 31 mēnešu laikā, no 2016.gada 1.jūnija līdz 2018.gada 31.decembrim. (Latvian)
0 references
Pharmaceutical, Biomedical and Medical Technology Competence Centre covers two scientific directions:•Pharmacy, Original Medicines and Generic Medicines – Research of active medical substances for the development of new medicinal products including paten release drugs, evaluation of specific substances for treatment of specific diseases, etc.;•Nature substances medicines, nutritional supplements, functional cosmetics – to develop new cosmetic products.The aim of the Competence Centre is to support at least 13 studies in accordance with defined research directions, to develop new products and technologies in the field of bio-competition, which will be developed in the field of bio-competition and to be implemented in the field of bio-competition.The aim of the Competence Centre is to support at least 13 studies in accordance with defined research directions, developing new products and technologies in the field of research, which will be implemented in the field of bio-competition.The aim of the Competence Centre is to support at least 13 studies in accordance with the defined research directions, to develop at least 13 research in the field of development of the project, and to support new products in the field of bio-competition, to be implemented in the field of bio-competition.The aim of the Competence Centre is to support at least 13 studies in accordance with the defined research directions, developing new products and technologies in the field of biotechnologies.The aim of the Competence Centre is to support at least 13 studies in accordance with the defined research directions, developing new products and technologies in the field of biotech industry, thus promoting the research of bio-competary industry.The aim of the Competence Centre is to support at least 13 studies in accordance with defined research directions, developing new products and technologies in the field of biotechnology, thus promoting the development of the bio-competion industry.The aim of the Competency Centre is to support at least 13 studies in accordance with the defined research directions, developing new products and technologies in the field of research, as well as in the field of bio-competition, thus promoting the development of the bio-competition industry.The aim of the Competency Centre is to support at least 13 studies in accordance with defined research directions, developing new products and technologies in the field of bio-competition, thus promoting the research of bio-competition industry.The aim of the Competency Centre is to support at least 13 studies in accordance with the defined research directions, to develop new products and technologies in the field of bio-competition.The aim of the Centre is to support at least 13 studies in accordance with the defined research directions, developing new products and technologies in the field of bio-competition, thus promoting the research of the bio-competition industry.The aim of the Competence Centre is to support at least 13 studies in accordance with the defined research directions, developing new products and technologies in the field of research, as well as in the field of biotechnologies.The aim of the Competence Centre is to support at least 13 studies in accordance with the defined research directions, developing new products and technologies in the field of biotechnologies, and introducing in the field of biotechnologies.The aim of the Competence Centre is to support at least 13 studies in accordance with the (English)
15 July 2021
0 references
Le Centre de compétences pour les technologies pharmaceutiques, biomédicales et médicales couvre deux volets scientifiques:•Farmation, princeps et médicaments génériques — recherche de substances médicales actives pour le développement de nouveaux médicaments, y compris l’évaluation de substances spécifiques pour le traitement de maladies spécifiques, etc.•Substances naturelles, compléments alimentaires, cosmétiques fonctionnels — pour développer de nouveaux produits cosmétiques, conformément aux tendances de l’industrie cosmétique.L’objectif du Centre de compétences est de soutenir au moins 13 recherches selon les orientations de recherche définies, en développant de nouveaux produits et technologies dans le secteur et en les introduisant dans la production, favorisant ainsi la coopération entre les secteurs de la recherche et de l’industrie, ainsi que la compétitivité des opérateurs industriels, le projet sera mis en œuvre dans le domaine de la stratégie de spécialisation intelligente en Lettonie — «Biomédecine, technologies médicales, biopharmaceutiques et biotechnologies». au moins 9 entrepreneurs qui introduiront de nouveaux produits ou technologies en production. Le coût total de la recherche du projet s’élève à plus de 7 millions d’euros, le montant prévu du soutien du Fonds européen de développement régional (ci-après dénommé «FEDER») — 3 206 250 EUR. Le projet devrait être mis en œuvre dans un délai de 31 mois, du 1er juin 2016 au 31 décembre 2018. (French)
25 November 2021
0 references
Das Kompetenzzentrum für Pharmazeutika, Biomedizin und Medizintechnik umfasst zwei wissenschaftliche Schwerpunkte:•Farmation, Originator und Generika – Forschung an Wirkstoffen für die Entwicklung neuer Arzneimittel, einschließlich der Bewertung spezifischer Stoffe zur Behandlung bestimmter Krankheiten usw.•Natürliche Stoffe, Nahrungsergänzungsmittel, funktionale Kosmetika – zur Entwicklung neuer kosmetischer Mittel entsprechend den Trends der Kosmetikindustrie.Ziel des Kompetenzzentrums ist es, mindestens 13 Forschungen nach den festgelegten Forschungsrichtungen zu unterstützen. durch die Entwicklung neuer Produkte und Technologien in der Branche und ihre Einführung in die Produktion, die Förderung der Zusammenarbeit zwischen Forschung und Industrie sowie die Steigerung der Wettbewerbsfähigkeit der Industrieakteure. Das Projekt wird auf dem Gebiet der Strategie für intelligente Spezialisierung in Lettland – „Biomedizin, Medizintechnik, Biopharmazeutika und Biotechnologien“ umgesetzt. mindestens 9 Unternehmer, die neue Produkte oder Technologien in der Produktion einführen werden, belaufen sich auf insgesamt mehr als 7 Millionen Euro, die geplante Förderung aus dem Europäischen Fonds für regionale Entwicklung (nachfolgend – EFRE) – 3 206 250 EUR. Das Projekt soll innerhalb von 31 Monaten, vom 1. Juni 2016 bis zum 31. Dezember 2018 durchgeführt werden. (German)
28 November 2021
0 references
Visa Latvija
0 references
Identifiers
1.2.1.1/16/A/006
0 references